Belgium is TOP biotech non-US hotspot

December 21, 2015 News BioVox

Genengnews, the US news agency for Genetic Engineering & Biotechnology, published a list of 12 non-US hotspots for biotechnology jobs. Belgium is one of them! Other European countries, including Germany, France, Ireland, Switzerland and the UK, account together with Belgium for the most locations outside the US.

Genengnews based their selection on the size of the clusters of research universities, profit research institutes, and businesses. Also recent announcements by companies about new facilities and locations of the job openings posted on the websites of eight pharma and biotech corporate giants – Amgen, AstraZeneca, Johnson & Johnson, Eli Lilly, GSK, Novartis, Pfizer and Roche were taken into account.

Belgium is known for UCB and the VIB, but also for its younger biotechs, of which several went public this year, such as Galapagos, Bone Therapeutics, Biocartis and Celyad.

Avatar photo

With a local focus and global reach, the news platform BioVox shares insights into the Benelux life sciences ecosystem with readers across the world. BioVox is an independent publisher, providing its community with quality content and first-row access to interesting breakthroughs and trends in biotech, medtech, agtech, pharma, and more. We shine a spotlight on the latest news and innovations from both our partners and community.

All posts

Subscribe to the BioVox newsletter